首页 >
法规速递
-
Document: Union list of critical medicines - version 2.1 (revision 1)-2026/1/19
2026-01-20查看详情 > -
Document: Agenda of the CAT meeting 18-20 February 2026-2026/2/18
2026-02-27查看详情 > -
Document: QRD Appendix II - Medical Dictionary for Regulatory Activities terminology to be used in section 4.8 'undesirable effects' of the summary of product characteristics-2026/3/25
2026-03-26查看详情 > -
Page: PRAC recommendations on safety signals-2026/5/4
2026-05-06查看详情 > -
Human Gene Therapy for Neurodegenerative Diseases (Final)-2022/10/21
2022-11-15查看详情 > -
国家药监局关于修订金莲清热制剂、接骨七厘制剂、尪痹制剂、通窍鼻炎制剂说明书的公告 （2023年第39号）-2023/4/13
2023-04-14查看详情 > -
《药品经营和使用质量监督管理办法》解读（二）-2023/10/13
2023-10-16查看详情 > -
国家药监局药审中心关于发布《化学仿制药口服制剂经肠内营养管给药体外对比研究技术指导原则》的通告（2025年第1号）-2025/1/9
2025-01-10查看详情 > -
Document: Union list of critical medicines: eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) / Product Management System (PMS) entries (outdated)-2025/2/14
2025-02-18查看详情 > -
Page: Grouping of variations: questions and answers-2025/3/25
2025-03-26查看详情 >
